213 related articles for article (PubMed ID: 1696955)
1. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.
Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M
J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955
[TBL] [Abstract][Full Text] [Related]
2. Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells.
Fang H; Pincus SH
J Virol; 1995 Jan; 69(1):75-81. PubMed ID: 7983770
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus.
Pincus SH; McClure J
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):332-6. PubMed ID: 8419938
[TBL] [Abstract][Full Text] [Related]
4. In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein.
Pincus SH; Cole RL; Hersh EM; Lake D; Masuho Y; Durda PJ; McClure J
J Immunol; 1991 Jun; 146(12):4315-24. PubMed ID: 1710247
[TBL] [Abstract][Full Text] [Related]
5. Processing of the envelope glycoprotein gp160 in immunotoxin-resistant cell lines chronically infected with human immunodeficiency virus type 1.
Duensing TD; Fang H; Dorward DW; Pincus SH
J Virol; 1995 Nov; 69(11):7122-31. PubMed ID: 7474132
[TBL] [Abstract][Full Text] [Related]
6. Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope.
Tschachler E; Buchow H; Gallo RC; Reitz MS
J Virol; 1990 May; 64(5):2250-9. PubMed ID: 2182910
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of human immunodeficiency virus type 1 variants diminished in the ability to induce syncytium-independent cytolysis.
Stevenson M; Haggerty S; Lamonica C; Mann AM; Meier C; Wasiak A
J Virol; 1990 Aug; 64(8):3792-803. PubMed ID: 1695254
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.
Till MA; Zolla-Pazner S; Gorny MK; Patton JS; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1987-91. PubMed ID: 2538826
[TBL] [Abstract][Full Text] [Related]
9. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations.
Henderson EE; Yang JY; Zhang RD; Bealer M
Virology; 1991 May; 182(1):186-98. PubMed ID: 1708929
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160.
Pincus SH; Wehrly K; Cole R; Fang H; Lewis GK; McClure J; Conley AJ; Wahren B; Posner MR; Notkins AL; Tilley SA; Pinter A; Eiden L; Teintze M; Dorward D; Tolstikov VV
AIDS Res Hum Retroviruses; 1996 Jul; 12(11):1041-51. PubMed ID: 8827220
[TBL] [Abstract][Full Text] [Related]
11. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells.
Shahabuddin M; Bentsman G; Volsky B; Rodriguez I; Volsky DJ
J Virol; 1996 Nov; 70(11):7992-8002. PubMed ID: 8892923
[TBL] [Abstract][Full Text] [Related]
12. Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein.
Bera TK; Kennedy PE; Berger EA; Barbas CF; Pastan I
Mol Med; 1998 Jun; 4(6):384-91. PubMed ID: 10780881
[TBL] [Abstract][Full Text] [Related]
13. Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.
Platt EJ; Madani N; Kozak SL; Kabat D
J Virol; 1997 Feb; 71(2):883-90. PubMed ID: 8995604
[TBL] [Abstract][Full Text] [Related]
14. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
15. Selective killing of HIV-infected cells by anti-gp120 immunotoxins.
Matsushita S; Koito A; Maeda Y; Hattori T; Takatsuki K
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):193-203. PubMed ID: 2328157
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro.
Kusumi K; Conway B; Cunningham S; Berson A; Evans C; Iversen AK; Colvin D; Gallo MV; Coutre S; Shpaer EG
J Virol; 1992 Feb; 66(2):875-85. PubMed ID: 1731112
[TBL] [Abstract][Full Text] [Related]
17. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.
Jabbar MA; Nayak DP
J Virol; 1990 Dec; 64(12):6297-304. PubMed ID: 2243395
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of infectious chimeric clones between human immunodeficiency virus type 1 and simian immunodeficiency virus from an African green monkey.
Shibata R; Sakai H; Kiyomasu T; Ishimoto A; Hayami M; Adachi A
J Virol; 1990 Dec; 64(12):5861-8. PubMed ID: 1700827
[TBL] [Abstract][Full Text] [Related]
19. Microinjection and expression of an infectious proviral clone and subgenomic envelope construct of a human immunodeficiency virus.
Boyd AL; Wood TG; Buckley A; Fischinger PJ; Gilden RV; Gonda MA
AIDS Res Hum Retroviruses; 1988 Feb; 4(1):31-41. PubMed ID: 2835071
[TBL] [Abstract][Full Text] [Related]
20. Infection of human monocyte-derived macrophages by human immunodeficiency virus mediated by cell-to-cell transmission.
St Luce S; Arts E; Geleziunas R; Bour S; Wainberg MA
J Med Virol; 1993 Sep; 41(1):71-8. PubMed ID: 7693862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
